Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2009 Aug;94(8):1175-7.
doi: 10.3324/haematol.2008.005330.

Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim

Case Reports

Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim

Jean Donadieu et al. Haematologica. 2009 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1A and B
Figure 1A and B
Figure 1A depicts the patient’s lifetime absolute neutrophil counts. Figure 1B depicts leukocyte and absolute neutrophil counts between the injection of 120 μg/kg peg filgrastim (Jan 10th, 2008) and death (Jan 25th, 2008).
Figure 2
Figure 2
(left). Unenhanced CT scan obtained three days after peg filgrastim administration, demonstrating marked enlargement of the main and right pulmonary arteries. The main pulmonary artery to aortic diameter ratio is greater than one. The maximal diameter of the pulmonary trunk is 42 mm.

References

    1. Dale DC, Bolyard AA, Schwinzer BG, et al. The Severe Chronic Neutropenia International Registry: 10-year Follow-up Report. Support Cancer Ther. 2006;3:220–31. - PubMed
    1. Donadieu J, Bader-Meunier B, Bertrand Y, Lachaux A, Labrune P, Gougerot-Pocidalo MA, et al. Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases. Nouv Rev Fr Hematol. 1994;35:529–34. - PubMed
    1. Lyman GH, Kuderer NM. Filgrastim in patients with neutropenia: potential effects on quality of life. Drugs. 2002;62 (Suppl 1):65–78. - PubMed
    1. Donadieu J, Barkaoui M, Bézard F, Bertrand Y, Pondarré C, Guibaud P. Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy. J Pediatr Hematol Oncol. 2000;22:188–9. - PubMed
    1. Humbert M, Labrune P, Simonneau G. Severe pulmonary arterial hypertension in type 1 glycogen storage disease. Eur J Pediatr. 2002;161 (Suppl 1):S93–S6. - PubMed